Singapore markets closed

Calithera Biosciences, Inc. (CALA)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.02000.0000 (0.00%)
At close: 09:30AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-101,924
-39,650
-115,088
-90,137
Depreciation & amortisation
255
255
280
364
Stock-based compensation
5,442
4,030
10,264
8,060
Change in working capital
-4,557
-7,426
-3,405
-3,963
Accounts receivable
1,515
-
-
-
Accounts payable
-1,920
-2,918
1,656
-58
Other working capital
-60,731
-43,741
-66,447
-84,373
Other non-cash items
41,980
1,130
41,647
1,506
Net cash provided by operating activities
-60,582
-43,608
-66,300
-84,312
Cash flows from investing activities
Investments in property, plant and equipment
-149
-133
-147
-61
Purchases of investments
0
0
0
-57,059
Sales/maturities of investments
0
0
8,000
146,080
Net cash used for investing activities
-149
-133
7,853
88,960
Cash flows from financing activities
Common stock issued
10,415
9,639
10,664
40,861
Other financing activities
-
-
-173
-
Net cash used provided by (used for) financing activities
10,306
9,655
10,668
42,061
Net change in cash
-50,425
-34,086
-47,779
46,709
Cash at beginning of period
84,763
59,807
107,586
60,877
Cash at end of period
34,338
25,721
59,807
107,586
Free cash flow
Operating cash flow
-60,582
-43,608
-66,300
-84,312
Capital expenditure
-149
-133
-147
-61
Free cash flow
-60,731
-43,741
-66,447
-84,373